KLK1 Polyclonal Antibody

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK1 is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. This protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.

The KLK1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of KLK1 protein in various biological samples. This antibody is produced using state-of-the-art techniques, ensuring high affinity and specificity towards KLK1.

KLK1, also known as tissue kallikrein 1, is a serine protease that plays a crucial role in the regulation of blood pressure and renal function. It is primarily expressed in the kidney, pancreas, and salivary glands. Dysregulation of KLK1 has been implicated in various diseases, including hypertension, renal disorders, and cancer.

The KLK1 Polyclonal Antibody offers exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA). It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results.

This antibody is supplied as a liquid formulation, ready for immediate use. It has been rigorously tested for quality and consistency, guaranteeing reproducible results. The KLK1 Polyclonal Antibody is available in various sizes to accommodate different experimental needs.

In summary, the KLK1 Polyclonal Antibody is a valuable tool for researchers studying KLK1 and its role in various physiological and pathological processes. Its high specificity, sensitivity, and reliability make it an essential component of any research project involving KLK1 protein analysis.